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1. Introduction 
Immunochemical studies of the major density 
classes established clearly the antigenic heterogeneity 
of the human plasma lipoprotein system [1-3] .  Re- 
cent chemical investigations have confirmed these ear- 
lier findings and demonstrated the presence of six 
antigenicalty distinct polypeptides designated as A-I,. 
A-II, C-I, C-II, C-Ill and LP-B* [4-6] .  An additional 
antigenic omponent detected predominantly in HDL 
[7-10] has been designated 'thin-line' polypeptide 
due to its characteristic appearance on double diffu- 
sion analyses of HDL with anti-HDL or anti-whole se- 
rum. Under such experimental conditions, the 'thin- 
line' polypeptide appears as a characteristic thin pre- 
cipitin line nearer the antigen well, while the major 
precipitin band due to LP-A is closer to the antibody 
well [9, 11]. The occurrence of 'thin-line' polypep- 
tide has also been demonstrated in LDL [11] and 
* Abbreviations: LDL, low density lipoproteins, lipoproteins 
of d 1.006-1.073 g/ml; HDL, high density lipoproteins, 
lipoproteins of d 1.073-1.210 g/ml; VHDL, very high den- 
sity lipoproteins, lipoproteins of d > 1.21 g/ml; c~-LP, 
c~-lipoproteins, lipoproteins with an electrophoretic mobility 
of a-globulins; LP-A, lipoprotein family A, lipoproteins 
characterized bythe presence of apolipoprotein A (ApoA); 
A-I and A-II, constitutive polypeptides ofLP-A; LP-B, lipo- 
protein family B, lipoproteins characterized bythe presence 
of apolipoprotein B (ApoB); LP-C, lipoprotein family C, 
lipoproteins characterized bythe presence of apolipoprotein 
C (ApoC); and C-I, C-II, and C-Ill are constitutive polypep- 
tides of LP-C. The ABC-nomenclature sed in this paper 
has been described previously [ 191. 
VHDL [ 12]. On 7% polyaerylamide g l electrophore- 
sis, the 'thin-line' polypeptide migrates into the re- 
gion between the A-II and C-II polypeptides [ 10]. 
A preliminary estimate indicates that this polypeptide 
accounts for 1-2% of the total protein content of 
normal HDL [ 10]. 
This report describes the isolation and partial char- 
acterization of this antigenic determinant previously 
referred to as 'thin-line' p01ypeptide. On the basis of 
these studies we suggest that 'thin-line' polypeptide 
be designated as apolipoprotein D and its correspond- 
ing lipoprotein as lipoprotein family D (LP-D). 
2. Materials and methods 
2.1. Isolation o f  human plasma HDL 3 
Plasma samples from lqoth fasting and non-fasting 
healthy oung men and women were obtained by 
plasmapheresis. Due to relatively low concentrations 
of 'thin-line' polypeptide, at least one liter of pooled 
plasma was used as starting material for each isolation. 
Plasma density was adjusted to 1.27 g/ml by adding 
solid KBr, and the solution was centrifuged in the 
Ti-60 rotor of the Spinco Model L 2-65B ultracentri- 
fuge at 150 000 g for 22 hr at 5°C. The density (d) 
of the top layer collected by tube-slicing was ad- 
justed to 1.12 g/ml, and the solution was centrifuged 
under the same conditions. After discarding lipopro- 
tein floating at d 1.12 g/ml, the infranate was ad- 
justed to d 1.27 g/ml and washed twice by centrifuga- 
tion at 150 000g for 44 hr. After washing, the top 
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layer (d 1.12-1.27 g/ml, HDL3) was dialyzed ex- 
haustively against distilled water and lyophilized. 
2.2. Isolation of 'thin-line' polypeptide 
Delipidization of lyophilized HDL 3 was carried out 
by five successivd extractions with chloroform-meth- 
anol (2: I, v/v) followed by two washes with diethyl 
ether. Delipidized HDL 3 (apoHDL3) was dissolved in 
10 ml of 8 M urea in 0.001 M K2HPO4, pH 8.0. The 
apoHDL 3 solution was diluted to 2 M with respect to 
urea by addition of 0.001 M K2HPO 4 (pH 8.0) and 
applied to a hydroxylapatite-cellulose column. The 
column (30 X 2.2 cm) was packed to a height of 15 
cm with a mixture of two volumes of settled hydroxyl- 
apatite (Bio-Rad Lab., Richmond, Calif.) and one vol- 
ume of settled microcrystalline c llulose (Baker, 
Phillipsburg, N.J.). Prior to sample application, the col- 
umn was washed with 1 M K2HPO4, pH 8.0, and equi- 
librated with 0.001 M K2HPO4, pH 8.0. After applica- 
tion of the sample, the columnwas eluted with 40-  
50 ml of 0.001 M K2HPO 4 buffer, pH 8.0. The eluted 
fraction was rechromatographed un er identical con- 
ditions. After the secohd chromatography, the eluted 
fraction was examined by basic polyacrylamide g l 
electrophoresis (PAGE). If more than one band was 
detected, rechromatography under identical condi- 
tions was repeated until only one band could be de- 
tected on PAGE. To remove urea, the purified frac- 
tion was lyophilized and then chromatographed on a 
Sephadex G-IO0 column (90 X 2.5 cm) which had 
been equilibrated with 2 M acetic acid. Fractions of 
5.0 ml were collected at a flow rate of 25 ml/hr, and 
the protein content of the eluant was monitored by 
absorbance at280 nm. Fractions corresponding to the 
principal protein peak were combined and lyophilized. 
2.3. lmmunochemical methods 
Double-diffusion and immunoelectrophoresis in 1% 
agarose gels were carried out according to previously 
described procedures [9]. Immunoprecipitin l es 
were stained with Amido black 10B and Oil red O. 
The preparation and characterization f monospecific 
antisera to human A-I, A-II, C-I, C-II, and C-Ill poly- 
peptides and LP-B have already been described [9]. 
Rabbit antisera to human ct-LP and albumin were pur- 
chased from Behringwerke A.G., Marburg an der Lahn, 
GFR. The commercial ntiserum to a-LP gave two 
precipitin lines with HDL 3 when tested by double dif- 
fusion analysis. One line corresponded to the 'thin- 
line' polypeptide and the other to LP-A [6, 9, 11]. 
The immunization of a rabbit with 'thin-line' poly- 
peptide was carried out with an isolated preparation 
further purified by preparative 7% polyacrylamide g l 
electrophoresis ona Buchler Fractophorator (Buchler 
Instr., Fort Lee, N.J.). Preparative PAGE was carried 
out on a larger scale according to the analytical pro- 
cedure described by Davis [ 13]. Eight molar urea was 
used in preparing the separating gel (4 ml) and 4 M 
urea in preparing the stacking el (2 ml). Approximate 
ly 8-10 mg of sample, dissolved in the stacking el 
solution, was applied to the polyacrylamide g l. 
Tris-glycine, pH 8.3, was used as the electrode and 
elution buffer. Fractions were collected at 2.5 min in- 
tervals utilizing a constant current of 10 mA. The elu- 
tion pattern was monitored by absorbance at280 nm 
and by analytical PAGE. Fractions displaying a single 
band on PAGE were combined and lyophilized. A
rabbit was injected intraperitoneally with 2.5 mg of 
this purified 'thin-line' polypeptide homogenized in 
1 ml of Freund's complete adjuvant. After one week, 
the animal was injected with an identical antigenic 
preparation. Antiserum was drawn by cardiac punc- 
ture three weeks following the initial injection. 
2.4. Analytical methods 
Basic 7% polyacrylamide g l electrophoresis has 
been described elsewhere [9]. Amino acid analyses 
were performed on a Beckman Model 120C amino 
acid analyzer by an accelerated automatic procedure 
on spherical resins [11 ]. Half-cystine was determined 
by the performic acid oxidation procedure. The val- 
ues for cysteic acid were corrected for the 94% recov- 
ery found by Moore [14]. Tryptophan was deter- 
mined by the p-toluenesulfonic a id hydrolysis pro- 
cedure [15]. Glucosamine content was estimated 
from the amino acid analyses [ 11 ]. 
3. Results 
Two successive fractionations on a hydroxy- 
apatite-cellulose column were usually sufficient o 
yield a 'thin-line' polypeptide preparation which was 
characterized bya single band on 7% PAGE (fig. 1). 
However, in some cases aminor component was present 
near the junction of the separating and stacking els. 
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Fig. 1. Basic polyacrylamide g l electrophoresis patterns of 
VLDL, ApoD ('thin-line' polypeptide) and ApoHDL 3. 
To remove this minor component and urea, gel filtra- 
tion on Sephadex G-100 was performed and 'thin-l ine' 
polypeptide was eluted as a major symmetrical peak 
(fig. 2). 
After lyophil ization, this major fraction reacted 
only with antiserum to 'thin-l ine' polypeptide (fig. 3). 
On double diffusion analyses, it gave a negative reac- 
tion with antibodies to LP-A, LP-B, A,I, A-II, C-I, 
C-II, C-III, and albumin (fig. 3). On basic 7% PAGE, 
the 'thin-l ine' polypeptide xhibited a single band 
with mobil ity between the A-II and C-II polypeptide 
bands (fig. 1). 
a-LP -A  
a-A-If ~ a-A-I 
a-A Ib  a-C-ITI 
a-  LP-B a-C-l] 
a-C  -I 
ApoD 
a-D ApoD 
Fig. 3. Double diffusion analysis in 1% agarose gel of princi- 
ple fraction eluted from the Sephadex G-100. Center well 
contains ApoD. a = anti. 
Table 1 
Amino acid composition of apolipoprotein D. 
Amino acids ApoD a A-I c A-II d 










100 V, 200 300 400 
ml 
Fig. 2. Elution pattern of ApoD on Sephadex G-100. Elution 
carried out with 2 M acetic acid. Arrow indicates void volume. 
Aspartic 83.5 64.0 33.0 
Threonine 44.8 35.8 61.0 
Serine 35.3 46.0 50.7 
Glutamic 99.4 130.4 155.2 
Proline 66.9 34.0 40.1 
Glycine 33.8 41.0 30.6 
Alanine 50.7 64.9 50.9 
Valine 50.2 45.8 60.1 
Half-cystine 9.7 b 0 10.0 
Methionine 6.3 7.7 8.9 
Isoleucine 37.2 1.8 9.8 
Leucine 56.2 135.0 90.2 
Tyrosine 25.9 21.0 40.7 
Phenylalanine 29.1 21.3 40.7 
Lysine 58.8 65.2 94.3 
Histidine 10.7 18.9 0 
Arginine 17.6 56.0 0 
Tryptophan 3.2 24.0 0 
Glucosamine 29.2 
a Average of three 24 hr hydrolyses. 
b Determined by performic acid oxidation. 
c Data from Edelstein et al. [16]. 
d Data from Scanu et al. [17]. 
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Amino acid analysis of 'thin-line' polypeptide indi- 
cated the presence of all the common amino acids, 
including half-cystine and tryptophan, and glucos- 
amine (table 1). The amino acid composition differed 
from those of the well characterized polypeptides of
the human plasrffa lipoprotein system [4, 5]. 
Antiserum to the 'thin-line' polypeptide r acted 
with HDL 3 and the purified polypeptide (fig. 4). Fu- 
sion of these two precipitin lines indicated clearly the 
identity of the isolated and delipidized 'thin-line' poly- 
peptide and its corresponding intact form as it exists 
in HDL 3. Furthermore, the precipitin line of purified 
'thin-line' polypeptide fused with one of the two pre- 
cipitin lines of HDL 3 when tested with antibodies to 
a-LP (fig. 4). As mentioned earlier, the second precipi- 
tin line of HDL3, closer to the antibody well, is that 
of LP-A. The antiserum to the 'thin-line' polypeptide 
gave no reaction with either A-I, A-II, C-I, C-II, C-Ill 
polypeptides, LP-B or albumin. 
The precipitin line of 'thin-line' polypeptide in
HDL 3 stained for both lipid and protein. 
4. Discussion 
We have concluded on the basis of immunological 
properties, electrophoretic mobility in 7% polyacryl- 
amide gel and characteristic amino acid and glucos- 
amine composition that 'thin.line' polypeptide is a 
newly isolated, distinct polypeptide of the human 
plasma lipoprotein system. It does not react with 
monospecific antibodies to A-I, A-II, C-I, C-II and 
C-III polypeptides, LP-B or albumin (fig. 3). Immuni- 
zation of a rabbit with this polypeptide induced the 
production of an antiserum which reacted positively 
only with its corresponding antigen. The mobility of 
'thin-line' polypeptide on 7% PAGE was intermediate 
between those of A-II and C-II polypeptide bands 
(fig. 1) and did not correspond to any of the previous- 
ly characterized lipoprotein polypeptides including 
the so-called arginine-rich polypeptide [18]. 
Double diffusion analyses (fig. 4) demonstrated 
that the isolated polypeptide was identical with the 
thin immunoprecipitin l es of HDL or HDL 3. The af- 
finity of the thin immunoprecipitin l es of HDL or 
HDL 3 for both lipid and protein stains indicated its 
lipoprotein character. The appearance of separate pre- 
cipitin lines of intact 'thin-line' lipoprotein and LP-A 
HDL3 
a-(1-LP ApoD 
. -D  
Fig. 4. Double diffusion analyses in 1% aragose gel of antise- 
rum to ApoD (a-D) and reactions of identity of antigens and 
antibodies to ApoD. a = anti. 
(fig. 4) and the already demonstrated non-identity of 
LP-A and 'thin-line' polypeptide [ 11 ] represent evi- 
dence that 'thin-line' polypeptide is not a constituent 
of LP-A molecules. 
These results uggest hat the 'thin-line' polypep- 
tide is the apolipoprotein of a distinct lipoprotein 
family present mainly, although not exclusively, in
HDL 3. According to the ABC-nomenclature [19], 
this protein moiety is designated as apolipoprotein D 
(ApoD) and its corresponding lipoprotein(s) as lipo- 
protein family D (LP-D). 
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